PATENT CLAIM ANALYSIS

Application Number: 16066946
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["514", "250000"]

Abstract:
The present invention provides a prophylactic or therapeutic agent for Alzheimer's disease (AD) containing a combination of two or more compounds selected from the group consisting of compounds shown by compound Nos. 1 to 130. Since these compounds are existing drugs that have already been confirmed actually for safety and pharmacokinetics in human, they can be a means for a pre-emptive treatment of people at risk of AD and in a stage before developing mild cognitive impairment (MCI).

Claim (Index 9):
The method according to  claim 7 , wherein the two or more compounds belong to two or more clusters selected from the group consisting of clusters 1, 2, 4 and 5.

Metadata:
- Claim Count in Document: 14.0
- Percentile: 94.0
- Lexical Diversity: 1.27941
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12672326', '13810826', '13058647', '13504325', '14368823']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8004919400269328
- 35 USC 102 Novelty (BERT): 0.5147635250438798
- Combined Prediction Score: 0.7719190985286275
- Mean Citation Score: 200.609666
- Max Citation Score: 204.43149
- Similarity Product: 103.09531182885648

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test